Discover 2,532 paid clinical trials in Fairfield, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,532
Nerve Transfer to Improve Function in High Level Tetraplegia
for
Cervical Spinal Cord Injury, Tetraplegia
Location: Stanford CA, Salt Lake City UT, Houston TX, St Louis MO,
Sponsor: Washington University School of Medicine
Sex: All
Age: 18 - 70+
Code: NCT06288763
Recruiting
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
for
Triple Negative Breast Cancer, Breast Cancer
Location: Stanford CA
Sponsor: Stanford University
Sex: All
Age: 18+
Code: NCT04768426
Phase2, Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
Location: Stanford CA, Portland OR, Gilbert AZ, Dallas TX,
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT06116110
Recruiting
Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR
for
Brain Disease
Location: Palo Alto CA
Sponsor: Stanford University
Sex: All
Age: 21+
Code: NCT04383808
Recruiting
REHAB Fontan Failure: A Trial of Cardiac Rehabilitation
for
Heart Failure Congenital, Single-ventricle
Location: Stanford CA, Nashville TN
Sponsor: Stanford University
Sex: All
Age: 18+
Code: NCT06150950
Recruiting
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
for
Sickle Cell Disease
Location: Palo Alto CA, Madera CA, Los Angeles CA, Torrance CA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 12+
Code: NCT06612268
Phase3, Recruiting
Generic Database of Very Low Birth Weight Infants
for
Infant, Newborn, Infant, Low Birth Weight,
Location: Palo Alto CA, San Diego CA, Salt Lake City UT,
Sponsor: NICHD Neonatal Research Network
Sex: All
Age: 0
Code: NCT00063063
Recruiting
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
for
Locally Advanced Solid Tumor
Location: Palo Alto CA, Salt Lake City UT, Grand Junction CO,
Sponsor: Tango Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05732831
Phase1, Phase2, Recruiting
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
for
Ductal Breast Carcinoma in Situ
Location: Stanford CA
Sponsor: Stanford University
Sex: Female
Age: 18+
Code: NCT03909282
Recruiting
Melodi Matrix™ in Breast Reconstruction
for
Breast Reconstruction
Location: Palo Alto CA, Salt Lake City UT, Rapid City SD,
Sponsor: Melodi Health, Inc.
Sex: Female
Age: 22+
Code: NCT06027996
Recruiting
Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel
for
Non-Hodgkin Lymphoma, Large B-cell Lymphoma
Location: Palo Alto CA
Sponsor: Stanford University
Sex: All
Age: 18+
Code: NCT05794958
Phase1, Recruiting
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Sponsor: Michael J. Fox Foundation for Parkinson's Research
Sex: All
Age: 18+
Code: NCT05065060
Recruiting
Aspiration in Acute Respiratory Failure Survivors 2
for
Dysphagia, Aspiration
Location: Stanford CA, Aurora CO, New Haven CT, Boston MA
Sponsor: University of Colorado, Denver
Sex: All
Age: 18+
Code: NCT05108896
Recruiting
Prevention of Postop Atrial Fibrillation Through Intraoperative Inducibility of Atrial Fibrillation and Amiodarone Treatment
for
Postoperative Atrial Fibrillation
Location: Stanford CA
Sponsor: Stanford University
Sex: All
Age: 18+
Code: NCT03868150
Recruiting
Telehealth-Enabled Versus In-Person Parent-Mediated Behavioral Treatment for Challenging Behaviors in Children With ASD
for
Autism Spectrum Disorder
Location: Stanford CA
Sponsor: Stanford University
Sex: All
Age: 2 - 7
Code: NCT05268796
Phase2, Phase3, Recruiting
Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease